CD4+ T cells migrate from airway to bone marrow after antigen inhalation in rats.
BACKGROUND
IL-5-producing T lymphocytes increase in rat bone marrow after inhalational challenge with allergen.


OBJECTIVE
To test the hypothesis that T cells migrate from the airways to the marrow, we examined the trafficking of T cells in Brown Norway rats after sensitization and challenge with ovalbumin.


METHODS
Purified CD4+ T cells, harvested from cervical lymph nodes of naive and ovalbumin-sensitized donors, were labeled with carboxy fluorescein diacetate succinimidyl ester; 20 x 10(6) cells were placed in the trachea of naive or sensitized recipients under anesthesia, and 18 hours later, animals were challenged with inhaled ovalbumin. Cells were harvested 24 hours later from the bone marrow, bronchoalveolar lavage fluid, lungs, the lung blood pool of cells, lung draining lymph nodes, peripheral blood, and spleen.


RESULTS
The number of carboxy fluorescein diacetate succinimidyl ester-positive cells, measured by fluorescence-activated cell sorter, in the bone marrow of ovalbumin sensitized, primed T-cell recipients was higher than either the sham-sensitized, primed T-cell recipients or sham-sensitized, naive T-cell recipients (P < .05). The number of eosinophils in both bone marrow and bronchoalveolar lavage fluid was increased in ovalbumin-sensitized, primed T-cell recipients. The expression of the T-cell chemoattractants eotaxin and IL-16, evaluated by immunohistochemistry, was higher in the bone marrow of ovalbumin-sensitized, primed T-cell recipients.


CONCLUSIONS
CD4+ T cells travel from airway to bone marrow after antigen inhalation. The homing of the CD4+ T cells might be facilitated by eotaxin and IL-16 expression in the bone marrow and might contribute to the stimulation of eosinophilopoiesis after airway allergen exposure.
Isogai
Susumu
S
Meakins Christie Laboratories, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Miyata
Shigeru
S
Taha
Rame
R
Yoshizawa
Yasuyuki
Y
Martin
James G
JG
Hamid
Qutayba
Q
D000280:Administration, Inhalation; D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D001854:Bone Marrow Cells / Q000166:cytology / Q000276:immunology*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000502:physiology*; D002465:Cell Movement; D054413:Chemokine CCL11; D019742:Chemokines, CC / Q000096:biosynthesis; D002634:Chemotaxis, Leukocyte; D004804:Eosinophils / Q000166:cytology / Q000276:immunology; D019410:Interleukin-16 / Q000096:biosynthesis; D008168:Lung / Q000166:cytology / Q000276:immunology*; D008297:Male; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D051381:Rats; D011914:Rats, Inbred BN; D015398:Signal Transduction
D000941:Antigens; C515458:Ccl11 protein, rat; D054413:Chemokine CCL11; D019742:Chemokines, CC; D019410:Interleukin-16; D010047:Ovalbumin